These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 6172392)
1. Epstein-Barr virus strain- and group-specific antigenic determinants detected by monoclonal antibodies. Mueller-Lantzsch N; Georg-Fries B; Herbst H; zur Hausen H; Braun DG Int J Cancer; 1981 Sep; 28(3):321-7. PubMed ID: 6172392 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody specific for capsid antigen of Epstein-Barr virus. Takada K; Fujiwara S; Yano S; Osato T Med Microbiol Immunol; 1983; 171(4):225-31. PubMed ID: 6304479 [TBL] [Abstract][Full Text] [Related]
3. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates. Franklin SM; North JR; Morgan AJ; Epstein MA J Gen Virol; 1981 Apr; 53(Pt 2):371-6. PubMed ID: 6167667 [TBL] [Abstract][Full Text] [Related]
4. [Studies on Epstein-Barr virus strain differences with monoclonal antibodies]. Yang ZH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Feb; 11(1):41-5. PubMed ID: 2548745 [TBL] [Abstract][Full Text] [Related]
5. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein. Qualtiere LF; Chase R; Vroman B; Pearson GR Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus induced proteins V: comparison of EBV-specific polypeptides from different virus strains. Georg-Fries B; Mueller-Lantzsch N Med Microbiol Immunol; 1982; 171(1):11-21. PubMed ID: 6289060 [TBL] [Abstract][Full Text] [Related]
7. A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies. Tsai CH; Glaser R Intervirology; 1991; 32(6):376-82. PubMed ID: 1657827 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Thorley-Lawson DA; Geilinger K Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5307-11. PubMed ID: 6254073 [TBL] [Abstract][Full Text] [Related]
9. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines. Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies. Dölken G; Hecht T; Röckel D; Hirsch FW Virology; 1987 Apr; 157(2):460-71. PubMed ID: 3029983 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. Orvell C; Norrby E; Mufson MA J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen. Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689 [TBL] [Abstract][Full Text] [Related]
14. The reactions of monoclonal antibodies with structural proteins of mumps virus. Orvell C J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553 [TBL] [Abstract][Full Text] [Related]
15. Biological activities of human recombinant interferon alpha/beta targeted by anti-Epstein-Barr virus monoclonal antibodies. Miescher-Granger S; Hochkeppel HK; Braun DG; Alkan SS FEBS Lett; 1985 Jan; 179(1):29-33. PubMed ID: 2981178 [TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of monoclonal antibodies specific for the R transactivator 185 of Epstein-Barr virus. Zhu YH; Wei YS; Li H; Liang WB; Du B; Zhang GQ; Zhang L J Virol Methods; 2007 Sep; 144(1-2):12-6. PubMed ID: 17532480 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. Rowe M; Evans HS; Young LS; Hennessy K; Kieff E; Rickinson AB J Gen Virol; 1987 Jun; 68 ( Pt 6)():1575-86. PubMed ID: 2438376 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel EBV-induced membrane glycoprotein of 43 kDa with H667 MAb. Sanchez-Pinel A; Bernad J; Rives H; Lapchine L; Icart J; Didier J Virology; 1991 Jan; 180(1):31-40. PubMed ID: 1845828 [TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody that neutralizes Epstein-Barr virus DNA polymerase activity. Tsai CH; Williams MV; Glaser R Intervirology; 1990; 31(2-4):215-22. PubMed ID: 2165046 [TBL] [Abstract][Full Text] [Related]
20. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. Pearson GR; Vroman B; Chase B; Sculley T; Hummel M; Kieff E J Virol; 1983 Jul; 47(1):193-201. PubMed ID: 6306272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]